The roles of the opioid peptides in controlling thyroid stimulating hormone release

Life Sciences ◽  
1982 ◽  
Vol 31 (22) ◽  
pp. 2529-2536 ◽  
Author(s):  
Allan M. Judd ◽  
George A. Hedge
1985 ◽  
Vol 15 (2) ◽  
Author(s):  
Antonio E. Pontiroli ◽  
Miriam Alberetto ◽  
Guido Pozza

PLoS ONE ◽  
2010 ◽  
Vol 5 (7) ◽  
pp. e11755 ◽  
Author(s):  
Sayaka Akieda-Asai ◽  
Nobuhiro Zaima ◽  
Koji Ikegami ◽  
Tomoaki Kahyo ◽  
Ikuko Yao ◽  
...  

1981 ◽  
Vol 10 (1) ◽  
pp. 51-57 ◽  
Author(s):  
Mark S. Gold ◽  
A. L. C. Pottash ◽  
David M. Martin ◽  
Lawrence B. Finn ◽  
Robert K. Davies

Ten female patients who satisfied objective criteria for the diagnosis of anorexia nervosa were given 500 ug of thyrotropin releasing hormone. Thyroid stimulating hormone and growth hormone responses were measured in duplicate by radioimmunoassay. These patients had a low normal Δ thyroid stimulating hormone but a delayed peak response. In addition, these patients had pathological growth hormone release in response to thyrotropin releasing hormone infusion. Both delayed peak thyroid stimulating hormone and growth hormone response to thyrotropin releasing hormone have been reported for patients with hypothalamic disorders.


1980 ◽  
Vol 58 (3) ◽  
pp. 326-329 ◽  
Author(s):  
M. E. Celis

The effects of Leu-enkephalin, Met-enkephalin, and β-endorphin on melanocyte-stimulating hormone (MSH) secretion were studied in vivo and in vitro. The three opioid peptides release MSH. In vitro this release is dose dependent for Met-enkephalin between 10 and 1000 ng/mL and for Leu-enkephalin between 10 and 100 ng/mL. β-Endorphin releases MSH at the low concentration of 1 ng/mL and the effect is dose dependent between 1 and 100 ng/mL. Naloxone reverses this effect. In vivo the three petptides release MSH.


2021 ◽  
Vol 2 (2) ◽  
pp. 265-272
Author(s):  
Dorian S. Houser ◽  
Cory Champagne ◽  
Daniel E. Crocker

Stimulation of the thyroid with thyroid-stimulating hormone (TSH) is a potentially useful diagnostic of thyroid dysfunction, but little is known about the response of the thyroid to TSH stimulation in bottlenose dolphins (Tursiops truncatus). To better characterize the response of the dolphin thyroid to TSH stimulation, five adult dolphins participated in a TSH stimulation study. Dolphins voluntarily beached onto a padded mat and were given a 1.5 mg intramuscular injection of human recombinant TSH. Blood samples collected the day prior, at multiple intervals the day of, and daily for three days after the injection were analyzed via radioimmunoassay for free and total triiodothyronine (fT3 and tT3), and free and total thyroxine (fT4 and tT4). Significant increases in circulating fT3, fT4, and tT4 were observed with peaks occurring for all hormones the day after the TSH injection; maximal increases were 44%, 47%, and 23% for each hormone, respectively. Temporal patterns in the hormones potentially reflected feedback mechanisms countering the surge in fT3 following stimulation. Though recombinant human TSH was effective at stimulating hormone release, it is likely that use of dolphin or dolphin-derived TSH would enhance the clinical utility of the stimulation test, as would the development of antibodies specific to dolphin TSH.


Sign in / Sign up

Export Citation Format

Share Document